Ask the Expert
Questions following the 8/14/18 webinar, “Breaking News In Breast And Ovarian Cancer And What Should I Make Of It” Q1: Is the thought from platinum-resistant ovarian cancer that, even if I am without evidence of disease from being on the PARP inhibitor Rubraca, do I… Continue reading
